Suppr超能文献

口服葡萄糖负荷后肢端肥大症患者和非肢端肥大症患者 GH 水平升高的矛盾现象。

Paradoxical GH increase after oral glucose load in subjects with and without acromegaly.

机构信息

Department of Medicine DIMED, University of Padova, Padua, Italy.

Endocrine Disease Unit, University-Hospital of Padova, Padua, Italy.

出版信息

J Endocrinol Invest. 2024 Jan;47(1):213-221. doi: 10.1007/s40618-023-02138-9. Epub 2023 Jun 21.

Abstract

OBJECTIVE

A paradoxical GH rise after the glucose load (GH-Par) is described in about one-third of acromegalic patients. Here, we evaluated the GH profile in subjects with and without acromegaly aiming to refine the definition of GH-Par.

DESIGN

Observational case-control study.

METHODS

Our cohort consisted of 60 acromegalic patients, and two groups of subjects presenting suppressed GH (< 0.4 µg/L) and high (non-acro, n = 116) or normal IGF-1 levels (non-acro, n = 55). The distribution of GH peaks ≥ 120% from baseline, insulin, and glucose levels were evaluated over a 180-min time interval after glucose intake.

RESULTS

A similar proportion of subjects in all three groups shows a GH ratio of ≥ 120% starting from 120 min. Re-considering the definition of paradoxical increase of GH within 90 min, we observed that the prevalence of GH peaks ≥ 120% was higher in acromegaly than in non-acro and non-acro (respectively 42%, 16%, and 7%, both p < 0.001). In patients without GH-Par, a late GH rebound was observed in the second part of the curve. Higher glucose peak (p = 0.038), slower decline after load, 20% higher glucose exposure (p = 0.015), and a higher prevalence of diabetes (p = 0.003) characterized acromegalic patients with GH-Par (with respect to those without).

CONCLUSIONS

GH-Par response may be defined as a 20% increase in the first 90 min after glucose challenge. GH-Par, common in acromegaly and associated with an increased prevalence of glucose metabolism abnormalities, is found also in a subset of non-acromegalic subjects with high IGF-1 levels, suggesting its possible involvement in the early phase of the disease.

摘要

目的

在大约三分之一的肢端肥大症患者中描述了葡萄糖负荷后 GH 升高的矛盾现象(GH-Par)。在这里,我们评估了肢端肥大症患者和非肢端肥大症患者的 GH 谱,旨在完善 GH-Par 的定义。

设计

观察性病例对照研究。

方法

我们的队列包括 60 例肢端肥大症患者,以及两组表现为 GH 抑制(<0.4μg/L)和高(非肢端肥大症,n=116)或正常 IGF-1 水平(非肢端肥大症,n=55)的患者。在葡萄糖摄入后 180 分钟的时间间隔内,评估了 GH 峰值≥120%基线、胰岛素和葡萄糖水平的分布。

结果

在所有三组患者中,从 120 分钟开始,具有 GH 比值≥120%的患者比例相似。重新考虑 90 分钟内 GH 增加的矛盾定义,我们观察到 GH 峰值≥120%的患病率在肢端肥大症患者中高于非肢端肥大症和非肢端肥大症患者(分别为 42%、16%和 7%,均 p<0.001)。在没有 GH-Par 的患者中,在曲线的第二部分观察到 GH 后期反弹。较高的葡萄糖峰值(p=0.038)、负荷后下降较慢、葡萄糖暴露增加 20%(p=0.015)以及糖尿病患病率较高(p=0.003),这些特征将肢端肥大症患者与 GH-Par 区分开来(与无 GH-Par 的患者相比)。

结论

GH-Par 反应可定义为葡萄糖刺激后前 90 分钟内 GH 增加 20%。GH-Par 常见于肢端肥大症,与葡萄糖代谢异常的患病率增加有关,也存在于具有高 IGF-1 水平的非肢端肥大症患者亚组中,提示其可能参与疾病的早期阶段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c3/10776735/bb5f642725b6/40618_2023_2138_Fig1_HTML.jpg

相似文献

1
Paradoxical GH increase after oral glucose load in subjects with and without acromegaly.
J Endocrinol Invest. 2024 Jan;47(1):213-221. doi: 10.1007/s40618-023-02138-9. Epub 2023 Jun 21.
2
Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load.
J Clin Endocrinol Metab. 2019 May 1;104(5):1637-1644. doi: 10.1210/jc.2018-00975.
7
Thyroid vascularity is increased in patients with active acromegaly.
Clin Endocrinol (Oxf). 2002 Jul;57(1):65-70. doi: 10.1046/j.1365-2265.2002.01562.x.
10
Whole-body insulin sensitivity rather than body-mass-index determines fasting and post-glucose-load growth hormone concentrations.
PLoS One. 2014 Dec 17;9(12):e115184. doi: 10.1371/journal.pone.0115184. eCollection 2014.

引用本文的文献

1
[Abnormal elevation of growth hormone in patients with pituitary adenoma combined with cirrhosis: A case report].
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Apr 18;57(2):400-402. doi: 10.19723/j.issn.1671-167X.2025.02.029.
2
The paradoxical GH response at OGTT does not predict Pasireotide efficacy but matters for glucose metabolism.
J Endocrinol Invest. 2025 May;48(5):1173-1183. doi: 10.1007/s40618-025-02534-3. Epub 2025 Jan 22.
3
Unlocking the Genetic Secrets of Acromegaly: Exploring the Role of Genetics in a Rare Disorder.
Curr Issues Mol Biol. 2024 Aug 20;46(8):9093-9121. doi: 10.3390/cimb46080538.
4
GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly.
J Clin Endocrinol Metab. 2025 Feb 18;110(3):715-729. doi: 10.1210/clinem/dgae583.

本文引用的文献

2
Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients.
Growth Horm IGF Res. 2022 Dec;67:101501. doi: 10.1016/j.ghir.2022.101501. Epub 2022 Sep 8.
3
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings.
Endocr Relat Cancer. 2022 Apr 29;29(5):273-284. doi: 10.1530/ERC-21-0258.
6
Clinical presentation and management of acromegaly in elderly patients.
Hormones (Athens). 2021 Mar;20(1):143-150. doi: 10.1007/s42000-020-00235-5. Epub 2020 Aug 25.
8
The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Rev Endocr Metab Disord. 2020 Mar;21(1):165-183. doi: 10.1007/s11154-019-09536-6.
9
Growth Hormone Response to Oral Glucose Load: From Normal to Pathological Conditions.
Neuroendocrinology. 2019;108(3):244-255. doi: 10.1159/000497214. Epub 2019 Jan 25.
10
Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load.
J Clin Endocrinol Metab. 2019 May 1;104(5):1637-1644. doi: 10.1210/jc.2018-00975.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验